Position in PFE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$6,571,720
-$1,298,514 QoQ
Shares Held
272,912
-2.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#525
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brookstone Capital Management holds $235,547,820 across 12 Drug Manufacturers - General names. PFE ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,395 | $78,436,731 | |
| 2 | JNJ |
Johnson & Johnson
|
184,287 | $46,803,369 | |
| 3 | AMGN |
Amgen Inc
|
97,295 | $35,232,465 | |
| 4 | ABBV |
AbbVie Inc.
|
91,033 | $22,907,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
144,784 | $18,292,010 | |
| 6 | MRK |
Merck & Co., Inc.
|
130,290 | $16,742,265 | |
| 7 | PFE |
Pfizer Inc
This page
|
272,912 | $6,571,720 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
94,227 | $5,429,359 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,571,720 | 272,912 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $7,870,234 | 280,279 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $6,735,873 | 270,517 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $6,863,827 | 269,381 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,789,902 | 115,095 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,958,343 | 116,746 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,895,829 | 109,153 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $3,586,534 | 123,930 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $3,415,070 | 122,054 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,470,582 | 89,030 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $12,437,452 | 432,006 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $15,004,515 | 452,352 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $8,802,576 | 239,983 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $4,083,590 | 100,088 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $5,350,480 | 104,420 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $4,442,952 | 101,530 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $5,481,818 | 104,555 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $5,492,227 | 106,089 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $10,090,523 | 170,881 | Shares | Sole | 2022-01-11 | |
| 2021-09-30 | $7,705,413 | 179,154 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $7,058,629 | 180,251 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $5,332,693 | 147,190 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $5,126,050 | 139,257 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $4,668,932 | 127,219 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $3,144,664 | 96,167 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $3,684,887 | 112,895 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||